Published in BMC Microbiol on May 25, 2011
Structural features and kinetic characterization of alanine racemase from Staphylococcus aureus (Mu50). Acta Crystallogr D Biol Crystallogr (2011) 0.94
Streptococcus pneumoniae folate biosynthesis responds to environmental CO2 levels. J Bacteriol (2013) 0.84
Crystal structures of lysine-preferred racemases, the non-antibiotic selectable markers for transgenic plants. PLoS One (2012) 0.78
Structural and biochemical analyses of alanine racemase from the multidrug-resistant Clostridium difficile strain 630. Acta Crystallogr D Biol Crystallogr (2014) 0.78
Structure of alanine racemase from Oenococcus oeni with bound pyridoxal 5'-phosphate. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.78
Crystallization and preliminary X-ray study of a thermostable alanine racemase from Thermoanaerobacter tengcongensis MB4. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.76
The structure of alanine racemase from Acinetobacter baumannii. Acta Crystallogr F Struct Biol Commun (2014) 0.76
Characterization and preliminary mutation analysis of a thermostable alanine racemase from Thermoanaerobacter tengcongensis MB4. Extremophiles (2013) 0.76
Crystal Structure of a Thermostable Alanine Racemase from Thermoanaerobacter tengcongensis MB4 Reveals the Role of Gln360 in Substrate Selection. PLoS One (2015) 0.75
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Solvent content of protein crystals. J Mol Biol (1968) 106.07
Inference of macromolecular assemblies from crystalline state. J Mol Biol (2007) 44.95
Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A (2001) 42.14
Jalview Version 2--a multiple sequence alignment editor and analysis workbench. Bioinformatics (2009) 31.84
Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr (2004) 31.52
PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr (2004) 23.86
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet (2009) 15.31
Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr D Biol Crystallogr (2006) 14.21
PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res (2004) 11.53
Databases in protein crystallography. Acta Crystallogr D Biol Crystallogr (1998) 4.18
Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis (2006) 3.74
The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother (2003) 3.61
Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev (2001) 3.25
Community-acquired pneumonia. Lancet (2003) 2.80
Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One (2009) 2.65
A common allosteric site and mechanism in caspases. Proc Natl Acad Sci U S A (2006) 2.12
ProtorP: a protein-protein interaction analysis server. Bioinformatics (2008) 2.09
Determination of the structure of alanine racemase from Bacillus stearothermophilus at 1.9-A resolution. Biochemistry (1997) 1.59
Factors affecting the level of alanine racemase in Escherichia coli. J Bacteriol (1972) 1.59
Pneumococcal vaccines and flu preparedness. Science (2007) 1.50
Streptococcus pneumoniae: does antimicrobial resistance matter? Semin Respir Crit Care Med (2009) 1.43
Thermostable alanine racemase from Bacillus stearothermophilus: molecular cloning of the gene, enzyme purification, and characterization. Biochemistry (1986) 1.34
A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery. Clin Infect Dis (1993) 1.21
Structure-based drug design. Nature (1996) 1.19
The antimicrobial resistance profile of Streptococcus pneumoniae. Clin Microbiol Infect (2009) 1.18
Evidence for a two-base mechanism involving tyrosine-265 from arginine-219 mutants of alanine racemase. Biochemistry (1999) 1.16
Reaction of alanine racemase with 1-aminoethylphosphonic acid forms a stable external aldimine. Biochemistry (1998) 1.16
Structures of an alanine racemase from Bacillus anthracis (BA0252) in the presence and absence of (R)-1-aminoethylphosphonic acid (L-Ala-P). Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 1.15
A side reaction of alanine racemase: transamination of cycloserine. Biochemistry (2003) 1.15
Structure of a Michaelis complex analogue: propionate binds in the substrate carboxylate site of alanine racemase. Biochemistry (1999) 1.12
Reaction mechanism of alanine racemase from Bacillus stearothermophilus: x-ray crystallographic studies of the enzyme bound with N-(5'-phosphopyridoxyl)alanine. J Biol Chem (2002) 1.11
The 1.9 A crystal structure of alanine racemase from Mycobacterium tuberculosis contains a conserved entryway into the active site. Biochemistry (2005) 1.11
Mycobacterium smegmatis D-Alanine Racemase Mutants Are Not Dependent on D-Alanine for Growth. Antimicrob Agents Chemother (2002) 1.10
On the function of the 14 A long internal cavity of histone deacetylase-like protein: implications for the design of histone deacetylase inhibitors. J Med Chem (2004) 1.09
Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004). Int J Antimicrob Agents (2008) 1.06
Structural evidence that alanine racemase from a D-cycloserine-producing microorganism exhibits resistance to its own product. J Biol Chem (2004) 1.06
Tyrosine 265 of alanine racemase serves as a base abstracting alpha-hydrogen from L-alanine: the counterpart residue to lysine 39 specific to D-alanine. J Biochem (1999) 1.06
Crystal structure at 1.45 A resolution of alanine racemase from a pathogenic bacterium, Pseudomonas aeruginosa, contains both internal and external aldimine forms. Biochemistry (2003) 1.05
Alanine racemase free energy profiles from global analyses of progress curves. J Am Chem Soc (2004) 1.03
Residues Asp164 and Glu165 at the substrate entryway function potently in substrate orientation of alanine racemase from E. coli: Enzymatic characterization with crystal structure analysis. Protein Sci (2008) 1.02
Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia. Clin Microbiol Infect (2006) 1.01
Prevalence of penicillin-resistant pneumococci in Houston, Texas. Am J Clin Pathol (1982) 1.01
Antibiotics in childhood pneumonia. Paediatr Respir Rev (2006) 0.99
Mutant analysis shows that alanine racemases from Pseudomonas aeruginosa and Escherichia coli are dimeric. J Bacteriol (2002) 0.97
Biochemical and structural characterization of alanine racemase from Bacillus anthracis (Ames). BMC Struct Biol (2009) 0.95
Correlation between catalytic activity and monomer-dimer equilibrium of bacterial alanine racemases. J Biochem (2010) 0.94
The potential use of mechanism-based enzyme inactivators in medicine. J Enzyme Inhib (1988) 0.94
The alanine racemase of Mycobacterium smegmatis is essential for growth in the absence of D-alanine. J Bacteriol (2007) 0.91
Structural insights into the alanine racemase from Enterococcus faecalis. Biochim Biophys Acta (2009) 0.90
Structure-based drug design: computational advances. Annu Rev Pharmacol Toxicol (1997) 0.90
Effect of a Y265F mutant on the transamination-based cycloserine inactivation of alanine racemase. Biochemistry (2005) 0.89
Antibiotic resistance. Arch Otolaryngol Head Neck Surg (1995) 0.89
Site-directed mutagenesis of Tyr354 in Geobacillus stearothermophilus alanine racemase identifies a role in controlling substrate specificity and a possible role in the evolution of antibiotic resistance. Chembiochem (2002) 0.89
The structure of mammalian serine racemase: evidence for conformational changes upon inhibitor binding. J Biol Chem (2010) 0.88
A structure-based design approach for the identification of novel inhibitors: application to an alanine racemase. J Comput Aided Mol Des (2002) 0.88
A model for enzyme-substrate interaction in alanine racemase. J Am Chem Soc (2001) 0.88
Subunit interaction of monomeric alanine racemases from four Shigella species in catalytic reaction. FEMS Microbiol Lett (2003) 0.86
Purification and preliminary crystallization of alanine racemase from Streptococcus pneumoniae. BMC Microbiol (2007) 0.86
Dimerization inhibitors of HIV-1 protease. Biol Chem (2002) 0.85
Purification of an alanine racemase from Streptococcus faecalis and analysis of its inactivation by (1-aminoethyl)phosphonic acid enantiomers. Biochemistry (1985) 0.83
A novel assay method for an amino acid racemase reaction based on circular dichroism. Biochem J (2005) 0.81
Cluster analysis of water molecules in alanine racemase and their putative structural role. Protein Eng Des Sel (2004) 0.81
Design and synthesis of new inhibitors of HIV-1 protease dimerization with conformationally constrained templates. Bioorg Med Chem Lett (2001) 0.79
Breaking the spell: drug discovery based on modulating protein-protein interactions. Expert Rev Proteomics (2004) 0.79
Role of the polycomb protein EED in the propagation of repressive histone marks. Nature (2009) 6.62
Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N Engl J Med (2002) 1.81
Evolutionary fates within a microbial population highlight an essential role for protein folding during natural selection. Mol Syst Biol (2010) 1.14
The 1.9 A crystal structure of alanine racemase from Mycobacterium tuberculosis contains a conserved entryway into the active site. Biochemistry (2005) 1.11
Crystal structure at 1.45 A resolution of alanine racemase from a pathogenic bacterium, Pseudomonas aeruginosa, contains both internal and external aldimine forms. Biochemistry (2003) 1.05
The crystal structure of Trichomonas vaginalis ferredoxin provides insight into metronidazole activation. J Mol Biol (2002) 1.02
Reactivity of reduced [2Fe-2S] ferredoxins parallels host susceptibility to nitroimidazoles. Antimicrob Agents Chemother (2003) 0.99
Biochemical and structural characterization of alanine racemase from Bacillus anthracis (Ames). BMC Struct Biol (2009) 0.95
Structural features and kinetic characterization of alanine racemase from Staphylococcus aureus (Mu50). Acta Crystallogr D Biol Crystallogr (2011) 0.94
The alanine racemase of Mycobacterium smegmatis is essential for growth in the absence of D-alanine. J Bacteriol (2007) 0.91
Functionalized viral nanoparticles as ultrasensitive reporters in lateral-flow assays. Analyst (2013) 0.90
Experimental evolution of adenylate kinase reveals contrasting strategies toward protein thermostability. Biophys J (2010) 0.89
New classes of alanine racemase inhibitors identified by high-throughput screening show antimicrobial activity against Mycobacterium tuberculosis. PLoS One (2011) 0.88
Inherent structural disorder and dimerisation of murine norovirus NS1-2 protein. PLoS One (2012) 0.87
Engineered 5S ribosomal RNAs displaying aptamers recognizing vascular endothelial growth factor and malachite green. J Mol Recognit (2009) 0.87
Purification and preliminary crystallization of alanine racemase from Streptococcus pneumoniae. BMC Microbiol (2007) 0.86
DNAzyme-mediated recovery of small recombinant RNAs from a 5S rRNA-derived chimera expressed in Escherichia coli. BMC Biotechnol (2010) 0.85
N(2)-substituted D,L-cycloserine derivatives: synthesis and evaluation as alanine racemase inhibitors. J Antibiot (Tokyo) (2003) 0.84
Crystal structure of Bacteroides thetaiotaomicron TetX2: a tetracycline degrading monooxygenase at 2.8 Å resolution. Proteins (2011) 0.84
Label-free, in situ SERS monitoring of individual DNA hybridization in microfluidics. Nanoscale (2014) 0.82
Detection of viruses by counting single fluorescent genetically biotinylated reporter immunophage using a lateral flow assay. ACS Appl Mater Interfaces (2015) 0.81
Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation. Biotechnol Lett (2014) 0.80
Rare target enrichment for ultrasensitive PCR detection using cot-rehybridization and duplex-specific nuclease. Anal Biochem (2011) 0.77
Carbohydrate binding sites in Candida albicans exo-β-1,3-glucanase and the role of the Phe-Phe 'clamp' at the active site entrance. FEBS J (2010) 0.77
Characterization and crystallization of active domains of a novel luciferase from a marine dinoflagellate. Acta Crystallogr D Biol Crystallogr (2003) 0.76
A peroxidase-active aptazyme as an isothermally amplifiable label in an aptazyme-linked oligonucleotide assay for low-picomolar IgE detection. Analyst (2012) 0.76
Crystallization and preliminary X-ray analysis of the chemokine-binding protein from orf virus (Poxviridae). Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 0.75
Recovery of small DNA fragments from serum using compaction precipitation. PLoS One (2012) 0.75
Molecular dynamics simulations of Trichomonas vaginalis ferredoxin show a loop-cap transition. Biophys J (2007) 0.75
Detection and typing of viruses using broadly sensitive cocktail-PCR and mass spectrometric cataloging: demonstration with dengue virus. J Mol Diagn (2012) 0.75
Unusual manifestations of disseminated Histoplasmosis in patients responding to antiretroviral therapy. Am J Med (2005) 0.75
Biophysical characterization of VEGF-aHt DNA aptamer interactions. Int J Biol Macromol (2013) 0.75